Maria L. Webb - Concepedia

Author

Maria L. Webb

Bristol-Myers Squibb (United States)

Also Known As

M L Webb, M Webb, M. L. WEBB, M. L. Webb, M. Webb, M.L. Webb, MARIA L. WEBB, Maria L Webb, Maria L. Webb, Maria Webb

127

Publications

Citations

H-Index

133

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Pennsylvania State University Bristol-Myers Squibb (Germany)Ligand Pharmaceuticals (United States)Bristol-Myers Squibb (Sweden)

About

Maria L. Webb is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	48	1.7K
2	Natural Sciences	14	15	578
3	Health Sciences	4	4	87
4	Engineering	3	3	121
5	Education	2	2	28

Maria L. Webb

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40 Jun Lu, Noel Byrne, John Wang, Nature Structural & Molecular Biology Signal TransductionMolecular PhysiologyBiochemistryG Protein-coupled ReceptorFunctional Selectivity	2017	194
The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ETA Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5- isoxazolyl)-1-naphthalenesulfonamide Philip D. Stein, John T. Hunt, David Floyd, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapy3,4-Dimethyl-5- IsoxazolylChemical Biology	1994	137
Changes in Serum Corticosterone Concentration of Laying Hens as a Response to Increased Population Density MADGI M. MASHALY, Maria L. Webb, Sandra L. Youtz, Poultry Science	1984	102
Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. H. Wéber, Maria L. Webb, R Serafino, Molecular Endocrinology Vasoactive PeptidesImmunologyCardiovascular FunctionCellular PhysiologyInflammation	1994	87
Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. Stanley R. Krystek, Pramathesh S. Patel, Patricia M. Rose, Journal of Biological Chemistry EngineeringImmunologyMolecular PharmacologyCell SignalingEta Mutants	1994	77
Selective functional inhibition of JAK‐3 is sufficient for efficacy in collagen‐induced arthritis in mice Tsung H. Lin, Martin Hegen, Elizabeth Quadros, Arthritis & Rheumatism Jak‐3 SelectivityImmunologyCell ProliferationWhole BloodMusculoskeletal Research	2010	74
Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of <i>N</i>-[[2‘-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1‘-biphenyl]- 2-yl]methyl]-<i>N</i>,3,3-trimethylbutanamide (BMS-207940), A Highly Potent and Orally Active ET<sub>A</sub> Selective Antagonist Natesan Murugesan, Zhengxiang Gu, Steven H. Spergel, Journal of Medicinal Chemistry Receptor Antagonist N-Molecular PharmacologyMedicinal ChemistryPharmacological StudyBiochemistry	2002	62
Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist. Martin L. Ogletree, Don N. Harris, William A. Schumacher, Journal of Pharmacology and Experimental Therapeutics	1993	60
Endothelins stimulate mitogen-activated protein kinase cascade through either ETA or ETB Yingjian Wang, Patricia M. Rose, Maria L. Webb, American Journal of Physiology-Cell Physiology ImmunologyMapk CascadeCellular PhysiologyInflammationSignaling Pathway	1994	58
Effect of in-house transport on murine plasma corticosterone concentration and blood lymphocyte populations C. K. Drozdowicz, T. A. Bowman, Maria L. Webb, American Journal of Veterinary Research	1990	58

Page 1